Default Category
-
Valeant Pharmaceuticals: Eroded Reputation and Stock Price
Mary Gillett; Amy HorrocksCase IVEY-9B20B014-EAccounting and ControlIn early January 2019, a recent Ivey Business School graduate logged into her online trading account to review her portfolio’s performance. As she scanned her investments, she paused at one stock in particular. It was time to make a decision regarding one of her most volatile stocks—Valeant Pharmaceuticals International Inc., recently renamed Bausch Health Companies Inc. The pharmaceutical company was once celebrated for its innovative business a...Starting at €8.20
-
Bixi Goes to New York
Yves Plourde; Jean-Louis SchaanCase IVEY-9B15M013-EEntrepreneurship, StrategyIn May 2011, the Public Bike System Company, based in Montreal, Canada, was preparing to answer a request for proposal by New York City to create a financially self-sustaining public bike-sharing system. Three years earlier, the company, owned by the Montreal Transit Authority, had created Bixi, a service that made bikes available to members through docking stations, powered by solar energy, spread across the city. Although its financial structur...Starting at €8.20
-
Car2go Montreal: The Electrification Opportunity
Yves Plourde; Felipe HelferCase IVEY-9B16M056-EStrategyIn 2015, the City of Montreal issued an international request for interest for the implementation of an all-electric carsharing service. This situation represented both a threat and an opportunity for car2go, a carsharing service company and a subsidiary of Daimler that had successfully operated 29 carsharing systems across Europe and North America. Would it be worthwhile for car2go to respond to the request for interest and, in doing so, adapt i...Starting at €8.20